Investment Rating - The industry investment rating is "Overweight (Maintain)" [1] Core Viewpoints - The report emphasizes that the brain-computer interface (BCI) industry is experiencing continuous innovation and rapid growth, becoming a crucial area for the integration of technological and industrial innovation [8] - The report highlights the government's recent policy initiatives aimed at enhancing the innovation capabilities of the BCI industry, which are expected to drive high-quality development and create new industrial pathways [8] Summary by Sections Industry Overview - The report focuses on the pharmaceutical and biotechnology industry, particularly the advancements in brain-computer interface technology [1] Recent Developments - A joint document from seven government departments outlines plans to boost the BCI industry, aiming for breakthroughs in key technologies by 2027 and establishing a robust industrial ecosystem by 2030 [3][4] Investment Recommendations - The report suggests monitoring companies such as Aipeng Medical, Innovation Medical, and Xiangyu Medical, which are positioned to benefit from the growth in the BCI sector [8]